COVID-19 & CancerFree As treatments get cancelled because of COVID-19, patients worry about adequacy of care April 17, 2020Vol.46 No.16By Alexandria Carolan
COVID-19 & CancerFree Doroshow: NCI to accrue patients for COVID-19 longitudinal cohortOngoing trials see significant decrease in accrual April 17, 2020Vol.46 No.16By Matthew Bin Han Ong
COVID-19 & CancerFree Lowy: “Our patients are counting on us, and we must not let them down”NCI Frederick lab takes aim at Covid-19 April 17, 2020Vol.46 No.16By Matthew Bin Han Ong
COVID-19 & CancerFreeNCI Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response April 14, 2020Vol.46 No.16By Matthew Bin Han Ong
Clinical RoundupFree Phase III TNBC ASCENT study to be stopped for compelling efficacy April 10, 2020Vol.46 No.15
Clinical RoundupFree Roswell Park reports extended survival among breast cancer survivors who exercise regularly April 10, 2020Vol.46 No.15
Clinical RoundupFree Drug combination fights resistance to lung cancer treatment April 10, 2020Vol.46 No.15
Drugs & TargetsFree FDA approves Braftovi + cetuximab for BRAFV600E-mutant metastatic CRC indication April 10, 2020Vol.46 No.15
Drugs & TargetsFree FDA approves luspatercept-aamt for anemia in adults with MDS April 10, 2020Vol.46 No.15
Drugs & TargetsFree Myriad receives reimbursement for the BRACAnalysis Diagnostic System in Japan April 10, 2020Vol.46 No.15
